This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (34)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

E. J. VAN SCOTT, M.D.; R. K. SHAW, M.D.; R. G. CROUNSE, M.D.; P. T. CONDIT, M.D., Ph.D.

Arch Dermatol. 1960;82(5):762-771.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Most basal-cell carcinomas of the skin are readily detectable and, being accessible, can be successfully treated either surgically or radiologically. In some few patients, however, lesions may be so numerous or attain such large size that attempts to eradicate the lesions by either of the above means meet with certain failings or shortcomings. In such cases the trial use of selected chemotherapeutic compounds seems warranted.

A number of chemical agents are known to have at least some measurable inhibitory effect on the growth or progression of some cancers in man. None, however, affect sufficient numbers of different types of cancers to warrant their general therapeutic use.

Among the compounds that have been subjected to clinical trial to date, the folic acid antagonists have produced, in both normal and neoplastic tissues, changes that seem to be significant enough to attract particular attention. In 1948, Farber et al.¹ reported that aminopterin . . . [Full Text PDF of this Article]

Author Affiliations
Bethesda, Md.; Seattle; Miami, Fla.; Oklahoma City

Dermatology Service, General Medicine Branch, National Cancer Institute, Bethesda, Md., and the National Institutes of Health, Public Health Service, U.S. Department of Health, Education, and Welfare.

Department of Medicine, University of Washington Medical School, Seattle (Dr. Shaw); Section of Dermatology, Miami University School of Medicine, Jackson Memorial Hospital, Miami (Dr. Crounse); the Oklahoma Medical Research Institute, Oklahoma City (Dr. Condit).

Footnotes
Submitted for publication April 4, 1960.

Read before the 80th Annual Meeting of the American Dermatological Association, Inc., Boca Raton, Fla., April 8-12, 1960.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?